After 20 years of research, RTI drug approved for drug-resistant tuberculosis


A new drug developed by a RTI International scientists has been granted U.S. Food and Drug Administration approval – offering hope to patients with drug-resistant tuberculosis.

Previous Seattle company plays key part in creating breakthrough tuberculosis treatment
Next Here's why Fifth Third is expanding in San Francisco